Article | July 13, 2026

Why Sponsors Are Moving Away From Multi-Vendor Trial Support

cro-vendor-selection-GettyImages-1220794892

Clinical trial operations are becoming more complex, yet many organizations still rely on fragmented, multi-vendor service models that introduce unnecessary friction. Disconnected systems for payments, travel coordination, and reimbursements create administrative strain for sites, increase out-of-pocket burdens for patients, and limit sponsors’ ability to track spend in real time.

A growing shift toward centralized platforms reflects the need for greater alignment across these critical functions. By unifying logistics, financial workflows, and data visibility, sponsors can streamline operations, reduce delays, and create a more consistent experience across trials. This approach also improves site engagement by reducing administrative workload and enables clearer, more predictable budgeting through integrated forecasting.

Ultimately, simplifying the service ecosystem helps remove barriers to participation and execution — keeping trials on track while improving outcomes for both patients and sites.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader